NOF (JP:4403) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NOF Corporation has revised its consolidated earnings and dividend forecasts for the fiscal year ending March 31, 2025, citing strong demand in the Functional Chemicals segment and a positive outlook for the rest of the fiscal year. The company expects full-year net sales, operating profit, ordinary profit, and profit attributable to owners to surpass previous forecasts, despite challenges in the Pharmaceuticals segment due to decreased demand from bio-ventures.
For further insights into JP:4403 stock, check out TipRanks’ Stock Analysis page.